Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LABP | AMGN | VRTX | REGN | GILD |
| Company | Landos Biopharma Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 22.93 | 331.95 | 495.67 | 1,179.20 | 79.43 |
| High | 22.94 | 335.66 | 500.25 | 1,191.33 | 80.25 |
| Low | 22.75 | 330.30 | 492.29 | 1,170.84 | 78.60 |
| Last | 22.93 | 333.83 | 495.89 | 1,184.69 | 79.00 |
| Change | +0.13 | +2.82 | +2.54 | +5.76 | -0.45 |
| % Change | +0.58% | +0.85% | +0.51% | +0.49% | -0.57% |
| Volume | 50,800 | 2,173,500 | 1,809,600 | 405,300 | 6,205,300 |
| 20-Day Average Volume | 11,285 | 1,939,180 | 1,175,450 | 443,830 | 5,394,440 |
| Previous Close | 22.80 | 331.01 | 493.35 | 1,178.93 | 79.45 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.35 | 325.70 | 478.45 | 1,158.30 | 75.47 |
| 20-Day Raw Stochastic | 99.03% | 93.70% | 89.67% | 83.55% | 84.02% |
| 20-Day Relative Strength | 81.09% | 57.39% | 59.44% | 65.34% | 65.84% |
| Weighted Alpha | +234.26 | +30.86 | +41.96 | +48.32 | +7.55 |
| Today's Opinion | 100% Buy | 96% Buy | 80% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 80% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.83% since 05/16/24 | +1.53% since 08/23/24 | +3.04% since 08/23/24 | -1.20% since 08/23/24 | +2.97% since 08/23/24 |
| Low | 22.20 on 05/20/24 | 325.39 on 08/28/24 | 476.38 on 08/27/24 | 1,170.84 on 08/30/24 | 76.42 on 08/26/24 |
| High | 22.94 on 05/23/24 | 335.66 on 08/30/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 | 80.25 on 08/30/24 |
| 1-Month | |||||
| %Chg | +3.52% since 04/23/24 | +0.17% since 07/30/24 | -1.34% since 07/30/24 | +9.92% since 07/30/24 | +1.22% since 07/30/24 |
| Low | 21.91 on 05/02/24 | 306.59 on 08/07/24 | 458.04 on 08/13/24 | 1,041.85 on 08/01/24 | 72.43 on 08/12/24 |
| High | 22.94 on 05/23/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 80.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +264.55% since 02/23/24 | +10.91% since 05/30/24 | +11.93% since 05/30/24 | +22.14% since 05/30/24 | +23.28% since 05/30/24 |
| Low | 5.57 on 03/11/24 | 295.30 on 06/13/24 | 443.47 on 05/31/24 | 967.43 on 05/31/24 | 62.07 on 05/31/24 |
| High | 22.94 on 05/23/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 80.25 on 08/30/24 |
| 6-Month | |||||
| %Chg | +418.78% since 11/22/23 | +21.91% since 02/29/24 | +17.86% since 02/29/24 | +22.63% since 02/29/24 | +9.57% since 02/29/24 |
| Low | 3.21 on 12/22/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 22.94 on 05/23/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 80.25 on 08/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 71,674 | 179,078,080 | 127,965,912 | 130,536,232 | 98,422,392 |
| Shares Outstanding, K | 3,126 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -21,940,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 6,954,000,000 |
| Last Quarter Net Income | -8,900,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,614,000,000 |
| 60-Month Beta | 0.14 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.43 on 05/09/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 05/10/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.80 | 0.00 | 30.69 | 16.90 |